| Patent Number |
Title Of Patent |
Date Issued |
| 7153866 |
Use of tempol for the treatment of Li-Fraumeni syndrome and ataxia telangiectasia |
December 26, 2006 |
| The present invention provides a method for the prophylactic and therapeutic treatment of cancer. The method comprises administering to an animal, preferably a mammal, more preferably a human, at risk for developing a cancer or having a cancer a nitroxide or a prodrug thereof, wherei |
| 6573720 |
Resonant structure for spatial and spectral-spatial imaging of free radical spin probes using ra |
June 3, 2003 |
| A radiofrequency (RF) coil design, suitable for detecting time domain electron paramagnetic resonance (EPR) responses from spin probes after pulsed excitation using radiofrequency irradiation (60-400 MHz), is configured in an array of numerous surface coils of appropriate diameters c |
| 5840759 |
Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agen |
November 24, 1998 |
| The present invention provides a method for sensitizing hypoxic cells in a tumor to radiation, wherein nitric oxide is delivered to target hypoxic cells through the administration of a nitric oxide-containing compound that spontaneously releases nitric oxide under physiological condition |
| 5837736 |
Nitric oxide-releasing compounds to sensitive cancerous cells to chemotherapeutic agents |
November 17, 1998 |
| The present invention provides a method for sensitizing hypoxic cells in a tumor to radiation, wherein nitric oxide is delivered to target hypoxic cells through the administration of a nitric oxide-containing compound that spontaneously releases nitric oxide under physiological condition |
| 5814667 |
Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers |
September 29, 1998 |
| The present invention provides a method for sensitizing hypoxic cells in a tumor to radiation, wherein nitric oxide is delivered to target hypoxic cells through the administration of a nitric oxide-containing compound that spontaneously releases nitric oxide under physiological condition |
| 5789447 |
Nitric oxide releasing compounds as protective agents in ischemia reperfusion injury |
August 4, 1998 |
| The present invention provides a method for treating oxygen free radical induced tissue damage associated with ischemia reperfusion injury, wherein nitric oxide is delivered to target cells/tissues through the administration of a nitric oxide-containing compound that spontaneously re |
| 5650442 |
Use of nitric oxide releasing compounds as hypoxic cell radiation sensitizers |
July 22, 1997 |
| The present invention provides a method for sensitizing hypoxic cells in a tumor to radiation, wherein nitric oxide is delivered to target hypoxic cells through the administration of a nitric oxide-containing compound that spontaneously releases nitric oxide under physiological condition |
